Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Pralidoxime
Drug ID BADD_D01815
Description Pralidoxime is an antidote to organophosphate pesticides and chemicals. Organophosphates bind to the esteratic site of acetylcholinesterase, which results initially in reversible inactivation of the enzyme. If given within 24 hours,after organophosphate exposure, pralidoxime reactivates the enzyme cholinesterase by cleaving the phosphate-ester bond formed between the organophosphate and acetylcholinesterase.
Indications and Usage For the treatment of poisoning due to those pesticides and chemicals of the organophosphate class which have anticholinesterase activity and in the control of overdosage by anticholinesterase drugs used in the treatment of myasthenia gravis.
Marketing Status Prescription; Discontinued
ATC Code V03AB04
DrugBank ID DB00733
KEGG ID C07400
MeSH ID C028797
PubChem ID 4884
TTD Drug ID D0X7NU
NDC Product Code Not Available
Synonyms pralidoxime | 2-PAM | 2-hydroxyiminomethyl-1-methylpyridinium | 1-methylpyridinium-2-aldoxime ion | pralidoxime bromide | 2-Pam bromide | pralidoxime chloride | 2-formyl-1-methylpyridinium chloride oxime | pyridine-2-aldoxime methochloride | 2-PAM chloride | pyridine-2-aldoxime methachloride | pralidoxime fumarate (1:1) | pralidoxime iodide | pyridine-2-aldoxime methiodide | pralidoxime lactate (1:1) | pralidoxime mesylate | 2-hydroxyiminomethylpyridinium methylmethanesulfonate | pralidoxime methyl sulfate | N-methylpyridinium 2-aldoxime methylsulfate | pralidoxime nitrate (1:1) | pralidoxime sulfate (1:1) | pralidoxime trichloroacetate | pralidoxime, 14C-labeled | Protopam | Protopam Chloride | Contrathion
Chemical Information
Molecular Formula C7H9N2O+
CAS Registry Number 6735-59-7
SMILES C[N+]1=CC=CC=C1C=NO
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Agitation19.06.02.001; 17.02.05.012--
Diplopia17.17.01.005; 06.02.06.002--Not Available
Dizziness02.01.02.004; 24.06.02.007; 17.02.05.003--
Haemoglobin13.01.05.018--Not Available
Headache17.14.01.001--
Hyperventilation22.02.01.006; 19.01.02.004--Not Available
Muscle necrosis15.05.05.007--Not Available
Muscular weakness15.05.06.001; 17.05.03.005--
Nausea07.01.07.001--
Pain08.01.08.004--
Somnolence19.02.05.003; 17.02.04.006--
Tachycardia02.03.02.007--Not Available
Vision blurred17.17.01.010; 06.02.06.007--
Haemorrhage24.07.01.002--Not Available
Inflammation08.01.05.007--Not Available
The 1th Page    1    Total 1 Pages